Healthcare provider profile · identity verified

Rachelle Andre, MD

Family Practice · LYNN, MA · NPI 1205112901

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	154
Levothyroxine Sodium	Levothyroxine Sodium	388	110
Alprazolam	Alprazolam	311	78
Amlodipine Besylate	Amlodipine Besylate	262	78
Oxycodone Hcl	Oxycodone Hcl	260	53
Lisinopril	Lisinopril	256	80
Rosuvastatin Calcium	Rosuvastatin Calcium	235	80
Losartan Potassium	Losartan Potassium	200	65
Omeprazole	Omeprazole	184	62
Ozempic	Semaglutide	181	36
Fluticasone Propionate	Fluticasone Propionate	169	78
Albuterol Sulfate Hfa	Albuterol Sulfate	164	65
Hydrochlorothiazide	Hydrochlorothiazide	157	56
Pregabalin	Pregabalin	157	31
Mounjaro	Tirzepatide	152	29
Pantoprazole Sodium	Pantoprazole Sodium	140	44
Gabapentin	Gabapentin	138	47
Lorazepam	Lorazepam	130	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	127	58
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	125	44
Escitalopram Oxalate	Escitalopram Oxalate	123	40
Metoprolol Succinate	Metoprolol Succinate	116	37
Zolpidem Tartrate	Zolpidem Tartrate	114	23
Furosemide	Furosemide	111	48
Montelukast Sodium	Montelukast Sodium	111	45
Bupropion Xl	Bupropion Hcl	106	33
Metformin Hcl	Metformin Hcl	101	39
Glipizide Er	Glipizide	98	31
Famotidine	Famotidine	85	31
Allopurinol	Allopurinol	83	22
Alendronate Sodium	Alendronate Sodium	82	22
Fluoxetine Hcl	Fluoxetine Hcl	82	19
Pravastatin Sodium	Pravastatin Sodium	77	28
Ondansetron Odt	Ondansetron	75	39
Triamcinolone Acetonide	Triamcinolone Acetonide	75	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	18
Potassium Chloride	Potassium Chloride	74	30
Simvastatin	Simvastatin	72	20
Methylprednisolone	Methylprednisolone	70	54
Prednisone	Prednisone	69	40
Trazodone Hcl	Trazodone Hcl	67	31
Duloxetine Hcl	Duloxetine Hcl	66	20
Tramadol Hcl	Tramadol Hcl	65	28
Sertraline Hcl	Sertraline Hcl	63	23
Valsartan	Valsartan	60	22
Clonazepam	Clonazepam	59	18
Metoprolol Tartrate	Metoprolol Tartrate	59	19
Naproxen	Naproxen	58	17
Mupirocin	Mupirocin	56	31
Fenofibrate	Fenofibrate Nanocrystallized	55	17
Baclofen	Baclofen	54	24
Nystatin	Nystatin	53	23
Azithromycin	Azithromycin	50	40
Citalopram Hbr	Citalopram Hydrobromide	49	21
Diclofenac Sodium	Diclofenac Sodium	46	16
Ezetimibe	Ezetimibe	45	15
Jardiance	Empagliflozin	44	16
Meloxicam	Meloxicam	43	12
Methocarbamol	Methocarbamol	43	suppressed
Synthroid	Levothyroxine Sodium	43	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	33
Doxycycline Hyclate	Doxycycline Hyclate	40	29
Oxybutynin Chloride Er	Oxybutynin Chloride	40	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	15
Diazepam	Diazepam	36	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Meclizine Hcl	Meclizine Hcl	35	15
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	12
Fentanyl	Fentanyl	33	suppressed
Spironolactone	Spironolactone	31	12
Metformin Hcl Er	Metformin Hcl	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	17
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	11
Eliquis	Apixaban	27	suppressed
Mometasone Furoate	Mometasone Furoate	27	suppressed
Wegovy	Semaglutide	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Oxycontin	Oxycodone Hcl	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	12
Celecoxib	Celecoxib	23	13
Atenolol	Atenolol	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fluconazole	Fluconazole	21	15
Carvedilol	Carvedilol	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Ibuprofen	Ibuprofen	20	13
Clobetasol Propionate	Clobetasol Propionate	19	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	18	suppressed
Metronidazole	Metronidazole	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Cefdinir	Cefdinir	17	11
Chlorthalidone	Chlorthalidone	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Linzess	Linaclotide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Risperidone	Risperidone	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Epinephrine	Epinephrine	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nystop	Nystatin	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error